Edition:
United States

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.42USD
11:41am EST
Change (% chg)

$0.02 (+4.41%)
Prev Close
$0.40
Open
$0.40
Day's High
$0.44
Day's Low
$0.38
Volume
30,183
Avg. Vol
49,946
52-wk High
$2.85
52-wk Low
$0.38

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Raymond Akers

58 2017 Executive Chairman of the Board, Co-Founder, Secretary, Chief Scientific Director

John Gormally

61 2017 Chief Executive Officer, Director

John Cheneval

2015 Executive Vice President, Sales and Marketing

Gary Rauch

59 2014 Senior Vice President - Finance, Treasurer

Christopher Ellis

2015 Vice President - Global Marketing